✦ LIBER ✦

Immunotherapy of ovarian cancer: II. In vitro generation and characterization of lymphokine-activated killer T cells from the peripheral blood of recurrent ovarian cancer patients

✍ Scribed by Joseph A. Lucci III; Alberto Manetta; Fabio Cappuccini; Elizabeth K. Ininns; Carmen A. Dett; Philip DiSaia; Robert S. Yamamoto; Michael L. Berman; Jacklin Soopikian; Gale A. Granger

Book ID: 119054182
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 697 KB
Volume: 45
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(92)90274-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapy of ovarian cancer. II. In

Immunotherapy of ovarian cancer. II. In vitro generation and characterization of lymphokine-activated killer T cells from the peripheral blood of recurrent ovarian cancer patients

✍ J.A. Lucci III; A Manetta; F Cappuccini; E.K. Ininns; C.A. Dett; P Disaia; R.S. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Generation of stimulated, lymphokine act

Generation of stimulated, lymphokine activated T killer (T-LAK) cells from the peripheral blood of normal donors and adult patients with recurrent glioblastoma

✍ Robert S. Yamamoto; Judy Coss; Bharathi Vayuvegula; Sudhir Gupta; Yancey Beamer; 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 736 KB

Recombinant interleukin-2 and lymphokine

Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. phenotypic and functional analysis of the peripheral blood mononuclear cells

✍ Claudio Fortis; Elisabetta Ferrero; Carlo Besana; Mauro Biffi; Silvia Heltai; La 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 735 KB

Natural killer (NK) and lymphokine-activ

Natural killer (NK) and lymphokine-activated killer (LAK) activities in a patient who recovered from cancer, and the characteristics of LAK cells generated from CD4−CD8− and CD8+ peripheral blood lymphocytes

✍ Fumio Komatsu; Kazunori Kihara 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 726 KB

Recombinant interleukin-2 and lymphokine

Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: II. characterization of cells cultured ex vivo and their contribution to the in vivo immunomodulation

✍ Claudio Fortis; Elisabetta Ferrero; Mauro Biffi; Silvia Heltai; Carlo Besana; Er 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 689 KB

An open-label, randomized trial of the e

An open-label, randomized trial of the effects of macrophage versus granulocyte colony-stimulating factor on natural killer cell activity, lymphokine activated killer cell activity, interleukin-2 production, and leukocyte count in patients after chemotherapy for ovarian cancer

✍ Mitsuaki Suzuki; Michitaka Ohwada; Yoshio Shimizu; Muneo Yamada; Ikuo Sato 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 381 KB